Niyogen Pharmaceuticals Private Limited
About Niyogen Pharmaceuticals Private Limited
Data last updated:
Niyogen Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 24 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2017PTC034686. Its GSTIN is 10AAFCN6446D1ZV (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kumari Pushpanjali and Rupam Sahay.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Girja Niwas Shahganj Lane Mahendru, Patna, Bihar, India – 800006.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.74 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net loss of ₹48,794 (net margin -2.5%) and EBITDA of -₹48,794 (EBITDA margin -2.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 61% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Niyogen Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGirja Niwas Shahganj Lane Mahendru, Patna, Bihar, India – 800006
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Niyogen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Niyogen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Niyogen Pharmaceuticals Private Limited, buy the company report.
Financials of Niyogen Pharmaceuticals Private Limited
FY 2024 filings availableNiyogen Pharmaceuticals Private Limited reported revenue of ₹19.74 Lakh (down 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 61%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹48,794 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹48,794 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.5% | ||||
| Net Profit Margin | -2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Niyogen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Niyogen Pharmaceuticals Private Limited
Niyogen Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumari Pushpanjali | Director | 24 May 2017 | 9 Years 5 Months | Current |
| Rupam Sahay | Director | 24 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Niyogen Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| DNC Pharmaceuticals Private Limited | ₹19.88 Lakh (FY 2024) | 8.0% | Hyderabad, Telangana, India | |||
| Niyogen Pharmaceuticals Private Limitedthis company | ₹19.74 Lakh (FY 2024) | -₹48,794 | -2.5% | -10.0% | Patna, Bihar, India | |
| Astrakind Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2024) | 275.0% | Jaipur, Rajasthan, India | |||
| Ridus Pharmaceuticals Private Limited | ₹19.74 Lakh (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Artenda Pharmaceuticals Private Limited | ₹19.71 Lakh (FY 2017) | 118.0% | Chennai, Tamil Nadu, India | |||
| Loenz Pharmaceuticals (OPC) Private Limited | ₹19.71 Lakh (FY 2021) | 302.0% | Saharsa, Bihar, India |
To see the full peer comparison of Niyogen Pharmaceuticals Private Limited, buy the company report.
Auditor
Niyogen Pharmaceuticals Private Limited is audited by ABHAY KUMAR for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHAY KUMAR | FY 2021 | 541717 |
Shareholding
The shareholding of Niyogen Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Niyogen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Niyogen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Niyogen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Niyogen Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAFCN6446D1ZV | Bihar | Active | 10 Jul 2018 |
To see the full GST registrations and return filing status of Niyogen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Niyogen Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Kumari Pushpanjali was appointed as Director on 24 May 2017.
Frequently asked questions
Niyogen Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 24 May 2017 (9+ years old) and is registered under CIN U74999BR2017PTC034686.
Niyogen Pharmaceuticals has 2 current directors:
- Kumari Pushpanjali - Director
- Rupam Sahay - Director
The latest financial statements of Niyogen Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Niyogen Pharmaceuticals is 10AAFCN6446D1ZV, registered in Bihar.
The CIN (Corporate Identification Number) of Niyogen Pharmaceuticals is U74999BR2017PTC034686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Niyogen Pharmaceuticals was incorporated on 24 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Niyogen Pharmaceuticals by revenue are DNC Pharmaceuticals Private Limited, Astrakind Pharmaceuticals Private Limited, Ridus Pharmaceuticals Private Limited, Artenda Pharmaceuticals Private Limited, Loenz Pharmaceuticals (OPC) Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Kumari Pushpanjali was appointed as Director on 24 May 2017. Rupam Sahay was appointed as Director on 24 May 2017.
The registered office of Niyogen Pharmaceuticals is at Girja Niwas Shahganj Lane Mahendru, Patna, Bihar, India – 800006.
Niyogen Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Niyogen Pharmaceuticals is active non-compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
